What is the role of lipo prostaglandin E1 in the treatment of cauda equina syndrome?

Updated: Jun 14, 2018
  • Author: Segun Toyin Dawodu, JD, MD, MS, MBA, LLM, FAAPMR, FAANEM; Chief Editor: Nicholas Lorenzo, MD, CPE, MHCM, FAAPL  more...
  • Print

Treatment with lipoprostaglandin E1 and its derivatives has been reported to be effective in increasing blood flow to the cauda equina region and reducing symptoms of pain and motor weakness. This treatment option should be reserved for patients with modest spinal stenosis with neurogenic claudication. No benefit has been reported in patients with more severe symptoms or patients with radicular symptoms.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!